EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA

Caitlin M Turner iD, Joy M Schmitz, Janet Ikeda, Glenn-Milo Santos

Addiction · 2025

DOI: 10.1111/add.70054 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Addiction, 2025. Verfasst von Caitlin M Turner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Naltrexone, Sexual and Gender Minorities, Alcoholism, Narcotic Antagonists. Die Arbeit nennt 47 Literaturangaben. Gefördert von: NIH HHS, NIAAA NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To determine whether there were within‐week associations between changes in alcohol use and changes in cannabis, cocaine or amphetamines use and, if so, to ascertain whether these associations varied by naltrexone use among adult sexual and gender minority men (SGMM) with mild and moderate alcohol use disorder (AUD).

Design

Secondary analyses of data from the Say When study, a double‐blind placebo‐controlled trial comparing targeted oral naltrexone (50 mg) to placebo for AUD over 12 weeks.

Setting

Procedures were conducted at the San Francisco Department of Public Health from May 2015 to November 2020, in San Francisco, California, USA.

Participants

98 of 120 SGMM who reported substance use beyond alcohol.

Measurements

Mixed effects logistic regression models tested associations between alcohol exposures [ethyl‐glucuronide (EtG)‐positive urine screens, past‐week binge drinking and past‐week binge drinking frequency] and same‐week use of other substances (positive urine screens for cannabis, cocaine or amphetamines), adjusting for age, race/ethnicity, income, depression score and treatment assignment. Associations by treatment assignment (naltrexone or placebo) were also evaluated.

Findings

Having a positive EtG urine screen was associated with higher odds of positive urine screens for cannabis [adjusted odds ratio (aOR) = 2.93, 95% confidence interval (95% CI) = 1.37–6.30, P = 0.006) or cocaine (aOR = 3.08, 95% CI = 1.52–6.23, P = 0.002). Each additional binge drinking day was associated with higher odds of having a positive urine screen for cocaine (aOR = 1.29, 95% CI = 1.04–1.60, P = 0.018). Among those receiving naltrexone, greater binge drinking days was associated with increased odds of having a positive urine screen for cocaine (aOR = 1.64, 95% CI = 1.18–2.27, P = 0.003), while results for cannabis and amphetamines were not statistically significant.

Conclusions

Among adult sexual and gender minority men enrolled in a clinical trial, alcohol use was positively associated with cannabis and cocaine use. Naltrexone may mitigate cocaine use in this group by moderating binge drinking or diminishing the rewarding effects of cocaethylene. Findings highlight the potential of targeted naltrexone as an intervention to address alcohol and cocaine co‐use and improve treatment outcomes in this underserved group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaltrexoneSexual and Gender MinoritiesAlcoholismNarcotic AntagonistsSubstance-Related DisordersAlcohol DrinkingHumansMaleAdultSan FranciscoDouble-Blind MethodMiddle AgedBinge DrinkingYoung AdultGlucuronatesCocaine-Related Disorders

Stichwörter der Autor:innen

AUDalcoholcocaineinteractionmixed effects modelsmultisubstancenaltrexonesexual and gender minority men

Substanzen

NaltrexoneNarcotic AntagonistsGlucuronatesethyl glucuronide

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
  • Center for Neurobehavioral Research on Addiction, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas at Houston, Houston, TX, USA.
  • Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA, USA.
  • Department of Community Health Systems, University of California, San Francisco, CA, USA.

ORCID-Profile: Caitlin M Turner

Förderung

  • NIH HHS
  • NIAAA NIH HHS
  • National Institutes of Health

Zitieren

APA

Turner, C. M., Schmitz, J. M., Ikeda, J., & Santos, G. M. (2025). Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA. Addiction. https://doi.org/10.1111/add.70054

Vancouver

Turner CM, Schmitz JM, Ikeda J, Santos GM. Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA. Addiction. 2025. doi:10.1111/add.70054

BibTeX
@article{Turner2025,
  author = {Turner, Caitlin M and Schmitz, Joy M and Ikeda, Janet and Santos, Glenn-Milo},
  title = {Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA},
  journal = {Addiction},
  year = {2025},
  doi = {10.1111/add.70054}
}
Kostenlos starten →